These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32863891)

  • 21. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
    Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
    Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The applications of machine learning to predict the forming of chemically stable amorphous solid dispersions prepared by hot-melt extrusion.
    Jiang J; Lu A; Ma X; Ouyang D; Williams RO
    Int J Pharm X; 2023 Dec; 5():100164. PubMed ID: 36798832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement.
    Ponnammal P; Kanaujia P; Yani Y; Ng WK; Tan RBH
    Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29547585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Ramadhani N; Shabir M; McConville C
    Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hot Melt Extrusion and Spray Drying of Co-amorphous Indomethacin-Arginine With Polymers.
    Lenz E; Löbmann K; Rades T; Knop K; Kleinebudde P
    J Pharm Sci; 2017 Jan; 106(1):302-312. PubMed ID: 27817830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
    Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
    Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of manufacturing factors on physical stability and solubility of solid dispersions containing a low glass transition temperature drug.
    Sakurai A; Sako K; Maitani Y
    Chem Pharm Bull (Tokyo); 2012; 60(11):1366-71. PubMed ID: 23124559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
    Tran P; Park JS
    Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance.
    Puppolo MM; Hughey JR; Dillon T; Storey D; Jansen-Varnum S
    AAPS PharmSciTech; 2017 Nov; 18(8):2841-2853. PubMed ID: 28560506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.
    LaFountaine JS; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):43-55. PubMed ID: 26307759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and performance assessment of solid dispersions prepared by hot melt extrusion and spray drying process.
    Agrawal AM; Dudhedia MS; Patel AD; Raikes MS
    Int J Pharm; 2013 Nov; 457(1):71-81. PubMed ID: 24013161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing.
    Ellenberger DJ; Miller DA; Kucera SU; Williams RO
    AAPS PharmSciTech; 2018 Jul; 19(5):1957-1970. PubMed ID: 29541940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S; Cathcart H; O'Reilly NJ
    Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.